{"id":16180,"date":"2013-01-29T02:30:00","date_gmt":"2013-01-29T01:30:00","guid":{"rendered":"http:\/\/www.fedaiisf.it\/da-cosa-dipende-la-fiducia-dei-medici-nei-brand\/"},"modified":"2013-01-29T02:30:00","modified_gmt":"2013-01-29T01:30:00","slug":"da-cosa-dipende-la-fiducia-dei-medici-nei-brand","status":"publish","type":"post","link":"https:\/\/www.fedaiisf.it\/en\/da-cosa-dipende-la-fiducia-dei-medici-nei-brand\/","title":{"rendered":"What does doctors' trust in brands depend on?"},"content":{"rendered":"

Doctors' trust in pharmaceutical brands depends on various factors: functional, but also emotional and related to the relationship that the 'white coat' has with the manufacturing company. <\/p>\n

<\/font><\/span><\/p>\n

This is highlighted by a research by 'Harris Interactive', a market research company which interviewed 1,034 American family doctors and specialists on their attitude towards 'designer' medicines for asthma, COPD, osteoporosis and rheumatoid arthritis and contraceptives.<\/p>\n

<\/font><\/span><\/p>\n

By obtaining an assessment of the brands in these categories based on five parameters, relating both to the product itself and to the company that produces it. "Our research - underlines Joseph Vorrasi, Senior Vice President of Healthcare Research - clearly demonstrates that confidence in a drug depends on factors that go beyond its effectiveness.<\/p>\n

<\/font><\/span><\/p>\n

The importance of the emotional component is further supported by the consistency with which opinion leaders distinguish between emotional and functional evaluation". <\/p>\n

<\/font><\/span><\/p>\n

Analysts therefore suggest that companies seize this opportunity: the various 'facets' of doctors' attitude towards a treatment can represent an opportunity to transfer their trust from a single product to a brand in general.<\/p>\n

<\/font><\/span><\/p>\n

Barbara Di Chiara\u2013 January 29, 2013 \u2013 PharmaKronos<\/span><\/i><\/p>\n

<\/span><\/p>\n

 <\/p>","protected":false},"excerpt":{"rendered":"

La fiducia dei medici nei confronti dei brand farmaceutici dipende da diversi fattori: funzionali, ma anche emotivi e correlati al rapporto che il ‘camice bianco’ ha con l’azienda produttrice. Lo evidenzia una ricerca di ‘Harris Interactive’, società di ricerche di mercato che ha intervistato 1.034 medici di famiglia e specialisti americani sul loro atteggiamento nei …<\/p>","protected":false},"author":1,"featured_media":9846,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[90],"tags":[],"class_list":["post-16180","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-fedaiisf-archivio-storico"],"amp_enabled":true,"_links":{"self":[{"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/posts\/16180","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/comments?post=16180"}],"version-history":[{"count":0,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/posts\/16180\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/media\/9846"}],"wp:attachment":[{"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/media?parent=16180"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/categories?post=16180"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/tags?post=16180"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}